Physician profile
Nathan Lafayette
NPI 1811283203
$37,048.46
in general payments reported to CMS, 2019-2025
10 companies · $4,264 in 2025
The $4,264 reported for 2025 was more than what 89% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $133 · 2020: $8,300 · 2022: $9,304 · 2023: $6,339 · 2024: $8,709 · 2025: $4,264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $18K · Food and Beverage: $1,312.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $18,000.00 |
| Food and Beverage | $1,311.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $35,814.63 | 2020-2025 | Davinci Xi, Da Vinci Surgical System |
| Tela Bio, INC. | $265.76 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Ethicon US, LLC | $248.18 | 2019-2022 | |
| Medtronic, INC. | $238.74 | 2024-2025 | Signia, Transorb |
| My01 INC. | $151.06 | 2024 | My01 Continuous Compartmental Pressure Monitor |
| W. L. Gore & Associates, INC. | $127.14 | 2023 | Gore Seamguard Bioabsorbable Staple Line Reinforce |
| Davol INC. | $112.15 | 2022 | |
| Baudax Bio INC. | $51.07 | 2022 | |
| Teleflex LLC | $21.36 | 2025 | Titan Sgs Bailout Chuck |
| Baxter Healthcare | $18.37 | 2025 | Perclot |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Lafayette listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.